LabplusS.A.

Other human health activities not elsewhere classified

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2023-02-09
Share capital
527 170,20 PLN
Activity description

Labplus is a company that provides online interpretation of laboratory test results, allowing users to understand their health status quickly. Patients can receive a personalized health report by answering a questionnaire about their symptoms and medical history, typically within minutes. The service aims to help individuals make sense of their test outcomes and suggests further actions or consultations with healthcare professionals.

Registered address
Wyspa Słodowa 7, 50-266 Wrocław, Poland
Website
labplus.plWebsite active
Social media
Electronic delivery address
AE:PL-82770-29083-WRAJE-20

Financials

The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue
This companyUSD 353.38kMedianUSD 92.16kAverageUSD 1.47m
Net profit
This companyUSD -195.74kMedianUSD 2.46kAverageUSD 170.36k
Operating costs
This companyUSD 493.23kMedianUSD 85.23kAverageUSD 1.19m
Assets
This companyUSD 2.32mMedianUSD 40.76kAverageUSD 1.02m

Bank accounts

Registered as a VAT taxpayer on 2023-02-15. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

MSiG notices

Publication dateEvent
Feb 21, 2023Commercial Companies Code notice

Public aid

7 public aid cases recorded, with a total value of $2,092,746.

PurposeGross amount
Aid for research and development projects: industrial research
—
Aid for research and development projects: experimental development
—
De minimis aid (in accordance with Commission Regulation 2023/2831)
—

European Funds

ProjectEU co-financing
AI-PRESCREEN- SYSTEM INTELIGENTNEJ PRESELEKCJI PACJENTÓW DO BADAŃ KLINICZNYCH
$1.7M
Technologia telemedyczna wspomagająca diagnostykę w oparciu o automatyczną analizę wyników badań laboratoryjnych z uwzględnieniem wywiadu medycznego
$1.2M

Tenders

No recorded participation in tenders.

Authorized Representatives

Siddarth Agrawal — President of the Management Board
Jakub Górowski — Management Board Member
Łukasz Górowski — Attorney-in-fact (joint)

Manner of representation

Two members of the management board acting jointly, or one member of the management board acting jointly with a commercial proxy, are authorized to make declarations of will on behalf of the company.

Supervisory board

Anadi Agrawal — Supervisory Board Member
Bartłomiej Lech Czyczerski — Supervisory Board Member
Tomasz Jastrzębski — Supervisory Board Member

Beneficial owners

Person
Siddarth Agrawal (33)

Competitors

Name
Hh24sp. z o.o.
Zapytaj Lekarzasp. z o.o.
Salubrissp. z o.o.
Laboratorium Analiz Lekarskich Laborsp. z o.o.
E-Przychodnia24sp. z o.o.
Prime Medicalsp. z o.o.
Mental Health Help Linesp. z o.o.
Fundacja Abdomed Całodobowa Pomoc MedycznaS.K.A.
Pragamedsp. z o.o.
Zadoktora.Plsp. z o.o.

Change history

DateEvent
2026-09-09Share capital change
2025-06-26Share capital change
2024-07-08Address change
2024-07-08Share capital change
2023-02-09Entered in the register

FAQ

Last updated: 2026-10-03